Novartis teams up with Eva Longoria to launch Kiss This 4 MBC to generate research funding and support for the metastatic breast cancer community
– Kiss This 4 MBC goes beyond raising awareness of metastatic breast cancer to generate an increase in public support and research... Read More
Clinical Trials for Metastatic Breast Cancer Webinar: April 21, Noon CST
MBCN Teams With Research Advocacy Network to Offer Webinar on Clinical Trials for Metastatic Breast Cancer DATE: Friday April 21, 2017 TIME:... Read More
Dramatic Advances in HER2+ Breast Cancer over the Past 10 Years
In an interview with OncLive, Dr. Sara Hurvitz, from UCLA, discusses ongoing advances that continue to revolutionize the treatment of patients with HER2+... Read More
Phase III Breast Cancer Drug Abemaciclib Improves PFS
This CDK inhibitor will ultimately join palbociclib and ribociclib as an option for heavily pretreated MBC ER/PR+ patients who would take... Read More
MBCN Selects University of Pittsburgh Cancer Institute’s Dr. Steffi Oesterreich as a 2017 recipient of a $100,000 Metastatic Breast Cancer Research Leadership Award
THE METASTATIC BREAST CANCER NETWORK SUPPORTS METASTATIC BREAST CANCER RESEARCHERS THROUGH CONTRIBUTIONS MADE TO MBCN IN MEMORY OF PATIENTS WHOSE LIVES WERE... Read More
MBCN Selects Johns Hopkins’ Dr. Andrew Ewald as a 2017 recipient of a $100,000 Metastatic Breast Cancer Research Leadership Award
THE METASTATIC BREAST CANCER NETWORK SUPPORTS METASTATIC BREAST CANCER RESEARCHERS THROUGH CONTRIBUTIONS MADE TO MBCN IN MEMORY OF PATIENTS WHOSE LIVES... Read More
2012 Ellen Moskowitz and Suzanne Hebert Leadership Grant Award: Dr. Patricia Steeg
For more than 20 years, in her laboratory at the National Cancer Institute, in Bethesda, Maryland, Dr. Patricia Steeg has been researching how... Read More
Additional 2015 MBCN Research Leadership Award recipients included Dr. Rita Nanda and Dr. Steven Chmura
Dr. Rita Nanda’s research has been directed toward the treatment of triple-negative metastatic breast cancer. She has sought to identify novel anti-tumor... Read More
MBCN’s Metastatic Breast Cancer Research Leadership Award 2015 recipients included Johns Hopkins’ Dr. Andrew Ewald and Baylor’s Dr. Matthew Ellis
Improving Knowledge About Metastasis Dr. Andrew Ewald, Assistant Professor in the Departments of Cell Biology and Oncology at the Johns Hopkins University... Read More
Pragmatism, Realism, and Optimism
[ASC Connection] Several weeks ago, I attended the Metastatic Breast Cancer Network (MBCN) Annual Meeting, hosted by MD Anderson Cancer Center. I... Read More